Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Martini

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Transplantation Proceedings|June 4, 2015
Comparison Between IGL-1 and HTK Preservation Solutions in Deceased Donor Liver TransplantationM H Meine, I Leipnitz, M L Zanotelli, et al.
American Journal of Clinical Oncology|December 22, 2020
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 AntibodyMehmet Akce, Yuan Liu, Katerina Zakka, et al.
The Oncologist|November 25, 2022
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsTony Z Zhuang, Deepak Ravindranathan, Yuan Liu, et al.
Urologic Oncology|October 24, 2022
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell CarcinomaEric Midenberg, Michelle I Higgins, Benjamin N Schmeusser, et al.
The Oncologist|March 13, 2020
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsDylan J Martini, Yuan Liu, Julie M Shabto, et al.
Data in Brief|November 25, 2022
Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinomaBenjamin N Schmeusser, Dattatraya H Patil, Eric Midenberg, et al.
Cancer|March 24, 2021
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinomaMichelle I Higgins, Dylan J Martini, Dattatraya H Patil, et al.
European Urology Oncology|September 29, 2019
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly-Khan A Lalani, Wanling Xie, David A Braun, et al.
Cancer Treatment and Research Communications|May 24, 2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinibDylan J Martini, Meredith R Kline, Yuan Liu, et al.
Transplantation Proceedings|April 18, 2018
Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World StudyM Mucenic, A Bandeira de Mello Brandao, C A Marroni, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Transplantation Proceedings|June 4, 2015
Comparison Between IGL-1 and HTK Preservation Solutions in Deceased Donor Liver TransplantationM H Meine, I Leipnitz, M L Zanotelli, et al.
American Journal of Clinical Oncology|December 22, 2020
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 AntibodyMehmet Akce, Yuan Liu, Katerina Zakka, et al.
The Oncologist|November 25, 2022
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsTony Z Zhuang, Deepak Ravindranathan, Yuan Liu, et al.
Urologic Oncology|October 24, 2022
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell CarcinomaEric Midenberg, Michelle I Higgins, Benjamin N Schmeusser, et al.
The Oncologist|March 13, 2020
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsDylan J Martini, Yuan Liu, Julie M Shabto, et al.
Data in Brief|November 25, 2022
Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinomaBenjamin N Schmeusser, Dattatraya H Patil, Eric Midenberg, et al.
Cancer|March 24, 2021
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinomaMichelle I Higgins, Dylan J Martini, Dattatraya H Patil, et al.
European Urology Oncology|September 29, 2019
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly-Khan A Lalani, Wanling Xie, David A Braun, et al.
Cancer Treatment and Research Communications|May 24, 2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinibDylan J Martini, Meredith R Kline, Yuan Liu, et al.
Transplantation Proceedings|April 18, 2018
Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World StudyM Mucenic, A Bandeira de Mello Brandao, C A Marroni, et al.
Pageof 12